| 7.17 Data as of May 20 |  -0.13 / -1.78%Today’s Change | 5.51 Today|||52-Week Range 10.96 | +11.16% Year-to-Date |
| Previous close | 7.30 |
| Today’s open | 7.25 |
| Day’s range | -- - -- |
| Volume | 454,069 |
| Average volume (3 months) | 212,090 |
| Market cap | $451.9M |
| Dividend yield | 5.58% |
| Earnings growth (last year) | -280.77% |
| Earnings growth (this year) | -43.88% |
| Earnings growth (next 5 years) | -55.00% |
| Revenue growth (last year) | -10.65% |
| P/E ratio | -- |
| Price/Sales | 1.64 |
| Price/Book | 2.32 |
| Today’s change | Today’s % change | |
|---|---|---|
| SGNTSagent Pharmaceutica... | +0.34 | +2.09% |
| DVAXDynavax Technologies... | -0.03 | -1.20% |
| HITKHi-Tech Pharmacal Co... | +0.68 | +2.11% |
| SCRSimcere Pharmaceutic... | +0.03 | +0.32% |
| Next reporting date | June 6, 2013 |
| EPS forecast (this quarter) | $0.05 |
| Annual revenue (last year) | $244.8M |
| Annual profit (last year) | -$28.9M |
| Net profit margin | -11.79% |
Sector Health Services |
Industry Services to the Health Industry |
President, CEO, COO & Director Steven M. West |
Chief Financial Officer G. Peter Dans, MBA |
Corporate headquarters Ottawa, Ontario |
.
